Nitrous Oxide Frequency of Use and Causes in Hospital in Turkey

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04124562

Enrollment

170

Registered

2019-10-11

Start date

2019-10-15

Completion date

2019-11-15

Last updated

2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Environmental-Pollution-Related Condition

Keywords

Nitrous oxide, Prevalence, Turkey

Brief summary

The prevalence of nitrous oxide use in hospitals in Turkey

Detailed description

Nitrous oxide has a long history of use in the healthcare field for over 150 years. However, this gas is slowly being abandoned for various reasons. The decrease in N2O use is probably due to its side effects and negative impact on global warming. Proven side effects include irreversible toxic effects on bone marrow, relative or absolute contraindications related to neuro and cardiac anesthesia, increased incidence of post-operative nausea and vomiting, increased risk of miscarriage in pregnant women (5), the greenhouse effect of nitrous oxide. In 2013, B. Husum et al. investigated the frequency of N2O use in public hospitals in Scandinavian countries and it was confirmed that N2O use was reduced and limited. According to the results of this research, N2O was administered with a volatile anesthetic agent in 21.5% of general anesthesia applications in Scandinavian countries. N2O was used as the second agent in Denmark by 2.4%, Finland by 17%, Iceland by 34.5, Norway by 32.1%, Sweden by 27.5%. In Turkey there are not enough reports of N2O use prevalence. In this study, we will investigate the extent of use and avoidance reasons N2O in Turkey. And we aim creating awareness.

Interventions

OTHERNitrous Oxide

Nitrous Oxide use ratio in Turkey's hospitals

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Inclusion criteria

Hospitals who accept to participate in Turkey \-

Exclusion criteria

Hospitals refusing to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
The percentage of nitrogen oxide use	A day	Percentage of nitrogen oxide use in a daily general anesthesia practice

Secondary

Measure	Time frame	Description
The percentage of nitrogen oxide use	A month	Percentage of nitrogen oxide use in a monthly general anesthesia practice

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026